Dierckx, T., Verstockt, B., Vermeire, S., & van Weyenbergh, J. (2019). GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD. J Crohns Colitis.
Chicago Style aipamenaDierckx, Tim, Bram Verstockt, Séverine Vermeire, and Johan van Weyenbergh. "GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, Is a Viable Biomarker for Disease Activity in IBD." J Crohns Colitis 2019.
MLA aipamenaDierckx, Tim, Bram Verstockt, Séverine Vermeire, and Johan van Weyenbergh. "GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, Is a Viable Biomarker for Disease Activity in IBD." J Crohns Colitis 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.